{"title":"Private-public partnerships not a threat to Canada's health care system.","authors":"Brett Belchetz","doi":"10.46747/cfp.7105297","DOIUrl":"10.46747/cfp.7105297","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 5","pages":"297-298"},"PeriodicalIF":2.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Benoît Corriveau, Gabrielle Denault, Rick Wang, Alexander Beyer, Maryam Daneshvarfard, Mylaine Breton, Neb Kovacina, Lindsay Hedden, Goldis Mitra, Michael E Green, Danielle Martin, Danielle Brown-Shreves, Jasmin Kay, Peter MacLeod, Clifton van der Linden, Tara Kiran
{"title":"Sociodemographic variation in use of and preferences for digital technologies among patients in primary care: Results from the OurCare national survey.","authors":"Benoît Corriveau, Gabrielle Denault, Rick Wang, Alexander Beyer, Maryam Daneshvarfard, Mylaine Breton, Neb Kovacina, Lindsay Hedden, Goldis Mitra, Michael E Green, Danielle Martin, Danielle Brown-Shreves, Jasmin Kay, Peter MacLeod, Clifton van der Linden, Tara Kiran","doi":"10.46747/cfp.7105324","DOIUrl":"10.46747/cfp.7105324","url":null,"abstract":"<p><strong>Objective: </strong>To assess the association between patient sociodemographic characteristics and adoption of and preferences for digital technologies in primary care.</p><p><strong>Design: </strong>Cross-sectional bilingual online survey conducted in the fall of 2022.</p><p><strong>Setting: </strong>Canada.</p><p><strong>Participants: </strong>Adults living in Canada aged 18 and older.</p><p><strong>Main outcome measures: </strong>Descriptive statistics were reviewed and a bivariate analysis was conducted of 8 outcomes by sociodemographic characteristic. Models included the following 8 self-reported characteristics: gender, age, province, level of education, level of income, rurality, whether the participant was born in Canada, and health status. Descriptive responses to a question on why video appointments were not important for some respondents were also examined.</p><p><strong>Results: </strong>Data were analyzed from 9279 completed responses. Compared to those earning more than $150,000, respondents earning less than $30,000 were less likely to have recently used email or secure messaging (adjusted odds ratio [aOR]=0.57, 95% CI 0.37 to 0.87) or video calls (aOR=0.65, 95% CI 0.31 to 1.37) or want to use email or secure messaging (aOR=0.71, 95% CI 0.51 to 0.97) or video calls (aOR=0.50, 95% CI 0.36 to 0.68). Compared to university graduates, respondents with a high school diploma or below were less likely to have used email or secure messaging (aOR=0.67, 95% CI 0.49 to 0.90) or video calls (aOR=0.42, 95% CI 0.24 to 0.76) or want to use email or secure messaging (aOR=0.74, 95% CI 0.60 to 0.91) or video calls (aOR=0.73, 95% CI 0.59 to 0.90). People earning less than $30,000 were less likely to have accessed personal health records (aOR=0.43, 95% CI 0.30 to 0.61) or place importance on accessing them (aOR=0.60, 95% CI 0.41 to 0.88). Similarly, people with a high school diploma or less were less likely to access personal health records (aOR=0.61, 95% CI 0.50 to 0.76) and place importance on accessing them (aOR=0.68, 95% CI 0.54 to 0.86).</p><p><strong>Conclusion: </strong>The results suggest that people living with a lower income or who have less formal education are less likely to have used digital technologies or consider them important. Further research and policy work should help to understand barriers to adoption of digital technologies and develop tailored interventions to enable equitable access to health care services.</p>","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 5","pages":"324-336"},"PeriodicalIF":2.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rocket Doctor mischaracterized in article.","authors":"William Cherniak, George Mastoras, Pamela Lai","doi":"10.46747/cfp.7104229","DOIUrl":"https://doi.org/10.46747/cfp.7104229","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"229"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Entre pragmatisme et idéalisme.","authors":"Michael Allan","doi":"10.46747/cfp.7104287","DOIUrl":"https://doi.org/10.46747/cfp.7104287","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"287"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144006829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Getting practical about the naive dreamers.","authors":"Michael Allan","doi":"10.46747/cfp.7104288","DOIUrl":"https://doi.org/10.46747/cfp.7104288","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"288"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144006830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Il est temps de mettre en doute les étiquettes d’alerte pour l’allergie à la pénicilline.","authors":"Émélie Braschi, Samantha S Moe","doi":"10.46747/cfp.7104e66","DOIUrl":"https://doi.org/10.46747/cfp.7104e66","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"e66-e67"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Approche de la stéatose hépatique en clinique: Diagnostic, prise en charge et nomenclature proposée.","authors":"Andrew Szilagyi, Nir Hilzenrat","doi":"10.46747/cfp.7104e56","DOIUrl":"https://doi.org/10.46747/cfp.7104e56","url":null,"abstract":"<p><strong>Objectif: </strong>Présenter une actualisation des plus récents faits concernant le diagnostic et les issues de la stéatose hépatique (SLD), passer en revue la nouvelle nomenclature qui s'applique à la SLD, et proposer une approche à l'endroit du diagnostic et de la prise en charge de la SLD.</p><p><strong>Sources de l'information: </strong>Des articles individuels publiés principalement au cours des 2 dernières années, recensés à l'aide de PubMed et Google Scholar.</p><p><strong>Message principal: </strong>La stéatose hépatique est l'une des maladies les plus fréquemment rencontrées en pratique générale. Ce problème est un important marqueur biologique du syndrome métabolique. Le diagnostic se fonde sur des examens non invasifs. Les complications connues du syndrome métabolique et d'une maladie hépatique avancée sont souvent présentes au moment du diagnostic. La marche à suivre devrait inclure l'évaluation des facteurs de risque cardiométaboliques et de la dysfonction hépatique progressive. Des différences subtiles existent entre les patients qui ont reçu un diagnostic de SLD. Les cliniciens devraient être au fait des changements dans la terminologie s'appliquant à la SLD. La prise en charge de la SLD peut s'appuyer sur un simple algorithme.</p><p><strong>Conclusion: </strong>Il serait nécessaire d'évaluer l'épidémie de SLD et sa nature systémique, de même que les facteurs individuels de risque de maladies cardiovasculaires qui lui sont associés, ainsi que les problèmes métaboliques comme la dyslipidémie, l'hypertension et le diabète de type 2.</p>","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"e56-e62"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144053395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Time to challenge penicillin allergy labels.","authors":"Émélie Braschi, Samantha S Moe","doi":"10.46747/cfp.7104261","DOIUrl":"https://doi.org/10.46747/cfp.7104261","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"261"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Journey of a pill.","authors":"Harjas Kaur, Fiona Parascandalo, Gail Krantzberg, Emma Ko, Neha Mathur, Amanjot Singh Gill, Falisha Razack, Myles Sergeant","doi":"10.46747/cfp.7104263","DOIUrl":"10.46747/cfp.7104263","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the global journey of a generic clonazepam pill to map steps of production, distribution, and disposal.</p><p><strong>Data sources: </strong>PubMed; Google Scholar; industry and market reports; gray literature; pharmaceutical databases (eg, PharmaCompass); export records; pharmacies in Hamilton, Ont; industry professionals and leaders such as pharmaceutical company vice presidents, professors, a supply chain insurance company, and sustainable procurement consulting companies; and an international not-for-profit company.</p><p><strong>Study selection: </strong>Data related to clonazepam's standard pharmaceutical production process, life cycle system boundaries, and most probable production locations were included in this review.</p><p><strong>Synthesis: </strong>This study depicts the estimated journey of a clonazepam pill's production and distribution, with the prescription being filled in Vancouver, BC. It begins with the extraction of salts to produce the active pharmaceutical ingredient. The main centres for clonazepam's active pharmaceutical ingredient and excipient salt extraction and production are in India and China. Quality testing and stocking occur elsewhere, such as within the European Union. The product is then shipped back to India for the next manufacturing stages. Excipients are shipped from China to India and are incorporated into formulation and tableting. The product is then sent to global markets for the final stages of pill formation and regional distribution. After shipment through Europe and Asia, the journey continues through several locations within the United States, specifically New Jersey, for the final stages of manufacturing. Once manufacturing is finalized in New Jersey, the pill is shipped to and repackaged in Tennessee for distribution and then sent to Canadian industry clusters, typically within the greater Toronto area in Ontario. Pills are then shipped to pharmacies and hospitals in Vancouver, BC, for consumer use. The total distance travelled in this scenario is approximately 63,162 km, not including the entire process of producing and shipping excipients or local retailer shipments.</p><p><strong>Conclusion: </strong>Health care prescribing practices have tangible environmental impacts and manufacturers should continue to invest in operational streamlining to reduce greenhouse gas emissions.</p>","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"263-269"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Quand et comment évaluer la capacité décisionnelle de vos patients?","authors":"Lesley Charles, Frank Molnar, Chris Frank","doi":"10.46747/cfp.7104e63","DOIUrl":"https://doi.org/10.46747/cfp.7104e63","url":null,"abstract":"","PeriodicalId":55288,"journal":{"name":"Canadian Family Physician","volume":"71 4","pages":"e63-e65"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144010384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}